Late Complications of COVID-19; a Systematic Review of Current Evidence

Affiliations

¹ Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
² Department of Radiology, School of Medicine, University of California, San Diego (UCSD), California, USA.
³ Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
⁴ School of medicine, Islamic Azad University, Tehran, Iran.
⁵ Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran.
⁶ Department of Global Health and Socioepidemiology, Graduate School of Medicine, Kyoto University, Kyoto. Japan.

Review

SeyedAhmad SeyedAlinaghi et al. Arch Acad Emerg Med. 2021.

. 2021 Jan 20;9(1):e14.

doi: 10.22037/aaem.v9i1.1058. eCollection 2021.

¹ Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
² Department of Radiology, School of Medicine, University of California, San Diego (UCSD), California, USA.
³ Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
⁴ School of medicine, Islamic Azad University, Tehran, Iran.
⁵ Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran.
⁶ Department of Global Health and Socioepidemiology, Graduate School of Medicine, Kyoto University, Kyoto. Japan.

No abstract available

Keywords: COVID-19; Late Onset Disorders; Long Term Adverse Effects; SARS-CoV-2; post-acute COVID-19 syndrome.

Figures

1. Orlandi M, Lepri G, Bruni C, Wang Y, Bartoloni A, Zammarchi L, et al. The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress. Clinical Rheumatology. 2020:1. - PMC - PubMed
1. Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer's research & therapy. 2020;12(1):69. - PMC - PubMed
1. Mehraeen E, Behnezhad F, Salehi MA, Noori T, Harandi H, SeyedAlinaghi S. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence. European Archives of Oto-Rhino-Laryngology. 2020:1–6. - PMC - PubMed
1. Mehraeen E, Hayati B, Saeidi S, Heydari M, Seyed Alinaghi S. Self-Care Instructions for People Not Requiring Hospitalization for Coronavirus Disease 2019 (COVID-19) Archives of Clinical Infectious Diseases. 2020;15(COVID-19)
1. SeyedAlinaghi S, Ghadimi M, Hajiabdolbaghi M, Rasoolinejad M, Abbasian L, Nezhad MH, et al. Prevalence of COVID-19-like symptoms among people living with HIV, and using antiretroviral therapy for prevention and treatment. Current HIV Research. 2020 - PubMed